Company profile
Tandem Therapeutics
Unlocking the matrix barrier to treat fibrotic diseases
- Industry
- Biotechnology Research
- Employees
- 4
- Headquarters
- Schlieren
- Founded
- 2023
- Office locations
- 1
Tandem Therapeutics company summary
Tandem Therapeutics is a company in the Biotechnology Research industry, headquartered in Schlieren, founded in 2023. On LinkedIn the company has around 4 employees.
What technology does Tandem Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Tandem Therapeutics
TANDEM Therapeutics is a discovery stage Swiss biopharmaceutical company bringing a novel precision targeting approaches to fibrosis and fibrotic cancers. We advance over 15 years of transformative research and development at ETH Zürich and Paul Scherrer Institut in the field of extracellular matrix biology and the critical role it plays in the pathology of fibrotic cancers & organ fibrosis. The therapeutic platform is based on Matrix Targeting Peptides (MTP) that conditionally target disease associated matrix alterations that are known to be directly associated with several fibrotic diseases.
Where is Tandem Therapeutics located?
Tandem Therapeutics lists 1 location.
Compare companies similar to Tandem Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Tandem Therapeutics tandem-tx.com | Biotechnology Research | 4 | 2023 | Schlieren |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Tandem Therapeutics
What does Tandem Therapeutics do?
TANDEM Therapeutics is a discovery stage Swiss biopharmaceutical company bringing a novel precision targeting approaches to fibrosis and fibrotic cancers. We advance over 15 years of transformative research and development at ETH Zürich and Paul Scherrer Institut in the field of extracellular matrix biology and the critical role it plays in the pathology of fibrotic cancers & organ fibrosis. The therapeutic platform is based on Matrix Targeting Peptides (MTP) that conditionally target disease associated matrix alterations that are known to be directly associated with several fibrotic diseases.
How many employees does Tandem Therapeutics have?
Tandem Therapeutics has around 4 employees on LinkedIn.
Where is Tandem Therapeutics headquartered?
Tandem Therapeutics is headquartered in Schlieren.
When was Tandem Therapeutics founded?
Tandem Therapeutics was founded in 2023.
Build a lead list from companies like Tandem Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.